2021
Results of a Phase 2b Dose Finding Study of Velsecorat, an Inhaled Non-Steroidal, Selective Glucocorticoid Receptor Modulator in Asthma (GRANIT)
Chupp G, Beeh K, Jauhiainen A, Necander S, Brown M, Wählby Hamrén U, Forsman H, Kurdyukova Y, Steele J, Astbury C, Psallidas I. Results of a Phase 2b Dose Finding Study of Velsecorat, an Inhaled Non-Steroidal, Selective Glucocorticoid Receptor Modulator in Asthma (GRANIT). 2021, a1202-a1202. DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1202.Peer-Reviewed Original Research
2019
Design of a Phase 2b Dose Finding Study of AZD7594, an Inhaled Non-Steroidal, Selective Glucocorticoid Receptor Modulator, for the Treatment of Asthma
Chupp G, Brown M, Beeh K, Wahlby-Hamren U, Ekelund A, Barkstedt E, Forsman H, Björnsson E, Jauhiainen A, Steele J, Psallidas I. Design of a Phase 2b Dose Finding Study of AZD7594, an Inhaled Non-Steroidal, Selective Glucocorticoid Receptor Modulator, for the Treatment of Asthma. 2019, a1315-a1315. DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1315.Peer-Reviewed Original Research